Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The trial attempts to optimize, standardize and simplify the characteristic diagnosis and
treatment program of the dominant diseases in our hospital-the sequelae of pelvic
inflammatory disease, so as to make it suitable for clinical diagnosis and treatment in
primary hospital.
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine